886 related articles for article (PubMed ID: 22544872)
1. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
2. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
[TBL] [Abstract][Full Text] [Related]
3. Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weinger JG; Davies P; Acker CM; Brosnan CF; Tsiperson V; Bayewitz A; Shafit-Zagardo B
J Neuropathol Exp Neurol; 2012 May; 71(5):422-33. PubMed ID: 22487860
[TBL] [Abstract][Full Text] [Related]
4. Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.
Litwak SA; Payne NL; Campanale N; Ozturk E; Lee JY; Petratos S; Siatskas C; Bakhuraysah M; Bernard CC
PLoS One; 2013; 8(12):e82101. PubMed ID: 24339996
[TBL] [Abstract][Full Text] [Related]
5. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
6. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
[TBL] [Abstract][Full Text] [Related]
7. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.
Karnezis T; Mandemakers W; McQualter JL; Zheng B; Ho PP; Jordan KA; Murray BM; Barres B; Tessier-Lavigne M; Bernard CC
Nat Neurosci; 2004 Jul; 7(7):736-44. PubMed ID: 15184901
[TBL] [Abstract][Full Text] [Related]
8. Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma.
Sekine Y; Algarate PT; Cafferty WBJ; Strittmatter SM
J Neurosci; 2019 Apr; 39(17):3204-3216. PubMed ID: 30804090
[TBL] [Abstract][Full Text] [Related]
9. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice.
Fink KL; Strittmatter SM; Cafferty WB
J Neurosci; 2015 Nov; 35(46):15403-18. PubMed ID: 26586827
[TBL] [Abstract][Full Text] [Related]
11. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.
Wang X; Hasan O; Arzeno A; Benowitz LI; Cafferty WB; Strittmatter SM
Exp Neurol; 2012 Sep; 237(1):55-69. PubMed ID: 22728374
[TBL] [Abstract][Full Text] [Related]
12. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
[TBL] [Abstract][Full Text] [Related]
13. Silencing Nogo-A promotes functional recovery in demyelinating disease.
Yang Y; Liu Y; Wei P; Peng H; Winger R; Hussain RZ; Ben LH; Cravens PD; Gocke AR; Puttaparthi K; Racke MK; McTigue DM; Lovett-Racke AE
Ann Neurol; 2010 Apr; 67(4):498-507. PubMed ID: 20437585
[TBL] [Abstract][Full Text] [Related]
14. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
15. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
Tsunoda I; Tanaka T; Terry EJ; Fujinami RS
Am J Pathol; 2007 Jan; 170(1):214-26. PubMed ID: 17200195
[TBL] [Abstract][Full Text] [Related]
16. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis.
Howell OW; Rundle JL; Garg A; Komada M; Brophy PJ; Reynolds R
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1017-1033. PubMed ID: 20838243
[TBL] [Abstract][Full Text] [Related]
17. Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
Steinbach K; McDonald CL; Reindl M; Schweigreiter R; Bandtlow C; Martin R
PLoS One; 2011; 6(11):e26341. PubMed ID: 22096481
[TBL] [Abstract][Full Text] [Related]
18. Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis.
Su KG; Savino C; Marracci G; Chaudhary P; Yu X; Morris B; Galipeau D; Giorgio M; Forte M; Bourdette D
Eur J Neurosci; 2012 Feb; 35(4):562-71. PubMed ID: 22277070
[TBL] [Abstract][Full Text] [Related]
19. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
20. Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.
Hassen GW; Feliberti J; Kesner L; Stracher A; Mokhtarian F
Brain Res; 2008 Oct; 1236():206-15. PubMed ID: 18725211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
